Myocardial Ischemia Without Obstructive Coronary Stenoses

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-08

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Coronary-related myocardial ischemia can result from obstructive epicardial stenosis or non-obstructive causes including coronary microcirculatory dysfunction and vasomotor disorders. This prospective study has been created in order to provide knowledge in the field of non-obstructive coronary artery disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Myocardial Ischemia Detection With a Combined Cardiovascular Magnetic Resonance and Biomarker Protocol

NCT05813210

Myocardial Ischemia Demand

NOT_YET_RECRUITING NA

Non Obstructive Versus Obstructive Coronary Artery Disease

NCT05738876

Non-Obstructive Coronary Artery Disease

COMPLETED

Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial

NCT04805814

Microvascular Angina Angina Pectoris Angina, Stable +3 more

ACTIVE_NOT_RECRUITING NA

Myocardial Ischemia in Non-obstructive Coronary Artery Disease

NCT01853527

Coronary Atherosclerosis Myocardial Ischemia

COMPLETED

Microvascular Dysfunction in Acute Myocardial Infarction (AMI) and Its Relation to Outcome

NCT01538303

ST Segment Elevation Myocardial Infarction

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All-comer patients referred for coronary physiological assessment with pressure-flow measurements and acetylcholine endothelial function test, aimed to investigate different aspects of non-obstructive coronary artery disease, will be enrolled. Coronary hemodynamics during adenosine or acetylcholine evaluation will be measured either with a physiology wire equipped with pressure and temperature sensors (Abbott), or with a physiology wire equipped with pressure sensor and Doppler (Philips). Non-endothelium-dependent functional assessment will be performed with intravenous or intracoronary adenosine administration following the standard practice. Endothelium-dependent functional assessment will be performed with intracoronary acetylcholine bolus administration following the standard practice, which includes continuous 12-lead ECG monitorization. Microcirculatory dysfunction and vasomotor disorders will be diagnosed according to the criteria from the last European expert consensus on Ischaemia with Non-Obstructive Coronary Arteries (INOCA). Medical therapy will be adjusted on the basis of physiology study results and patients will be followed at 30 days, 1-, 2- and 5-years either at the outpatient clinic or by telephone contact. The Seattle Questionnaire of Angina will be applied during follow-up for obtaining an objective characterisation of the angina status.

OBJECTIVES OF THE STUDY:

* To investigate the coronary hemodynamics across the spectrum of coronary microcirculatory dysfunction.
* To investigate the coronary hemodynamics across the spectrum of vasomotor disorders.
* To investigate the impact of coronary microcirculatory dysfunction on clinical outcomes and patient symptoms at long-term follow-up.
* To investigate the impact of coronary vasomotor disorders on clinical outcomes and patient symptoms at long-term follow-up.
* To investigate the impact of a stratified medical therapy (guided by invasive physiology study) on patient symptoms.
* To investigate the role of microcirculatory dysfunction and vasomotor disorders in different settings of ischemic heart disease (i.e., recurrent angina despite successful percutaneous coronary intervention; myocardial infarction without obstructive coronary artery disease; left ventricular dysfunction (either systolic or diastolic) with or without heart failure).
* To develop new, alternative methods aimed to assess the coronary microcirculation.
* To investigate the role of myocardial bridging on myocardial ischemia generating mechanisms.
* To document safety of intracoronary testing in routine clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Ischemia Non-Obstructive Coronary Atherosclerosis Microvascular Coronary Artery Disease Vasospastic Angina Myocardial Bridging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Myocardial ischemia without obstructive coronary stenosis

Invasive coronary endothelium-dependent and non-endothelium-dependent physiological assessment

Intervention Type DIAGNOSTIC_TEST

Coronary hemodynamics and vessel anatomical measures obtained during adenosine and acetylcholine evaluation with a dedicated physiology wire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Invasive coronary endothelium-dependent and non-endothelium-dependent physiological assessment

Coronary hemodynamics and vessel anatomical measures obtained during adenosine and acetylcholine evaluation with a dedicated physiology wire

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent available.
* Age ≥ 18 years.
* Patient eligible for invasive physiological assessment with adenosine and / or acetylcholine.

Exclusion Criteria

* Hemodynamic instability.
* Anticipated technical issues for physiology wire measurements.
* Culprit vessel of acute coronary syndrome
* Contraindications for adenosine administration.
* Contraindications for acetylcholine test.
* Reduced life expectancy (less than 1 year).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No